반응식
[CH3:1][C:2]1[CH:3]=[C:4]([CH:24]=[CH:25][CH:26]=1)[O:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]2[C:17]3=[N:18][S:19](=[O:23])(=[O:22])[CH2:20][CH2:21][N:16]3[CH:15]=[CH:14][CH:13]=2)=[CH:8][CH:7]=1>C1COCC1.CO.[Pt](=O)=O>[CH3:1][C:2]1[CH:3]=[C:4]([CH:24]=[CH:25][CH:26]=1)[O:5][C:6]1[CH:7]=[CH:8][C:9]([CH:12]2[C:17]3=[N:18][S:19](=[O:22])(=[O:23])[CH2:20][CH2:21][N:16]3[CH2:15][CH2:14][CH2:13]2)=[CH:10][CH:11]=1참가 물질
5
반응물 1
생성물 1
시약·촉매·용매 3
반응 조건
- 온도
- 50 °C
실험 절차
Platinum(IV) oxide (30 mg) was added to a solution of 9-[4-(3-methylphenoxy)phenyl]-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide (357 mg) in THF (dry) (80 mL) and MeOH (80 mL) and the mixture was stirred at 50° C. under hydrogen for 6 hr. Activated carbon was added and the insoluble solid was removed by filtration through NH-silica gel/Celite pad (eluted with EtOAc) and the filtrate was concentrated in vacuo. The residue was crystallized from MeCN-THF/IPE to give the title compound (243.5 mg) as colorless crystals.
후처리
- additionActivated carbon was added
- customthe insoluble solid was removed by filtration through NH-silica gel/Celite pad (eluted with EtOAc)
- concentrationthe filtrate was concentrated in vacuo
- customThe residue was crystallized from MeCN-THF/IPE
출처 및 근거
- ORD 기록
- ord-b1fa1223068d49bebed7de900cb2ab92
- 출처 데이터셋
- uspto-grants-2014_07
- 특허 번호
- US08778934B2
연결된 노트
불러오는 중…